This cohort study evaluates if neighborhood deprivation is associated with thicker (greater than 2 mm) cutaneous melanoma diagnosis after controlling for individual-level characteristics in the US veteran population.
A dermatology expert provides comprehensive insights into prurigo nodularis, discussing its disproportionate impact on middle-aged adults and immunocompromised individuals, the evolution of treatment from traditional…
LEO Pharma reveals promising interim results for tralokinumab in treating moderate to severe atopic dermatitis on hands, enhancing patient quality of life.
VYNE Therapeutics updates on VYN202, revealing promising early results in psoriasis treatment despite a clinical hold due to safety concerns.
The US Food and Drug Administration (FDA) recently approved lenacapavir, marketed as Yeztugo, as the first twice-yearly preexposure prophylaxis (PrEP) that reduces HIV risk.
New 16-week data from the phase 2 APEX clinical trial demonstrated the anti-IL-13 antibody’s efficacy across all key endpoints.
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
This cohort study evaluates the association between educational level and disability progression in patients with multiple sclerosis.
This cohort study assesses whether there were changes in the use of cannabis, cigarettes, and electronic nicotine delivery systems among US adults during 5 years…
Explore special articles published online first to coincide with presentations at the Endocrine Society (ENDO).
